1. nscl.pdf, https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (accessed 9 May 2023).
2.
Timmerman RD, Hu C, Michalski JM et al. Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer. JAMA Oncol 2018; 4: 1287-1288.
3.
Sebastian NT, Webb A, Shilo K et al. A PI3K gene expression signature predicts for recurrence in early-stage non–small cell lung cancer treated with stereotactic body radiation therapy (SBRT). Cancer 2023; 129: 3971-3977.
4.
Owen D, Siva S, Salama JK et al. Some like it hot: The value of dose and hot spots in lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2023; 117: 1-5.
5.
Herrmann H, Seppenwoolde Y, Georg D et al. Image guidance: past and future of radiotherapy. Radiologe 2019; 59: 21-27.
6.
Brooks ED, Verma V, Senan S et al. Salvage therapy for locoregional recurrence after stereotactic ablative radiotherapy for early-stage NSCLC. J Thorac Oncol 2020; 15: 176-189.
7.
Sultan S, Ullman K, Ester E et al. Non-surgical therapies for early-stage non-small cell lung cancer: A systematic review. Washington (DC): Department of Veterans Affairs (US), http://www.ncbi.nlm.nih.gov/books/NBK592710/ (2023, accessed 21 August 2023).
8.
Yoon SM, Suh R, Abtin F et al. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation. Radiat Oncol Lond Engl 2021; 16: 99.
9.
Yoon SM, Deng J, Wong K et al. CT-Guided Interstitial HDR Brachytherapy for Malignant Lung Lesions: Experience from University of California Los Angeles. In: Mohnike K, Ricke J, Corradini S (Eds.). Manual on Image-Guided Brachytherapy of Inner Organs: Technique, Indications and Evidence. Springer International Publishing Cham; 153-178.
10.
Ricke J, Wust P, Wieners G et al. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest 2005; 127: 2237-2242.
11.
Peters N, Wieners G, Pech M et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlenther Onkol 2008; 184: 296-301.
12.
Tselis N, Ferentinos K, Kolotas C et al. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2011; 6: 545-552.
13.
Sharma DN, Rath GK, Thulkar S et al. Computerized tomography-guided percutaneous high-dose-rate interstitial brachytherapy for malignant lung lesions. J Cancer Res Ther 2011; 7: 174-179.
14.
Benedict SH, Yenice KM, Followill D et al. Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med Phys 2010; 37: 4078-4101.
15.
Andratschke N, Willmann J, Appelt AL et al. European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol 2022; 23: e469-e478.
16.
Antonoff MB, Correa AM, Sepesi B et al. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 2017; 154: 689-699.
17.
Genshaft SJ, Suh RD, Abtin F et al. Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology. J Vasc Interv Radiol JVIR 2021; 32: 1241.e1-1241.e12.
18.
Li J, Zhang L, Xie Q et al. Comparison of clinical efficacy and complications of 125I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma. J Contemp Brachytherapy 2018; 10: 360-367.
19.
Doggett SW, Chino S, Lempert T. A novel approach for salvage treatment of non-small-cell lung cancer: percutaneous CT fluoroscopy-guided permanent seed brachytherapy for salvage treatment of lung cancer: long-term results of a case series. J Contemp Brachytherapy 2019; 11: 174-179.
20.
Rulach R, Ball D, Chua KLM et al. An International Expert Survey on the indications and practice of radical thoracic reirradiation for non-small cell lung cancer. Adv Radiat Oncol 2021; 6: 100653.
21.
Viani GA, Arruda CV, De Fendi LI. Effectiveness and safety of reirradiation with stereotactic ablative radiotherapy of lung cancer after a first course of thoracic radiation: A meta-analysis. Am J Clin Oncol 2020; 43: 575-581.
22.
Bari BD, Filippi AR, Mazzola R et al. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies. Cancer Treat Rev 2015; 41: 511-518.
23.
John C, Dal Bello R, Andratschke N et al. In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO). Sci Rep 2021; 11: 4590.
24.
Brooks ED, Wang X, De B et al. An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a “no-treat zone”. Radiat Oncol 2022; 17: 4.
25.
Simone C, Amini A, Chetty I et al. American Radium Society (ARS) and American College of Radiology (ACR) Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys 2020; 108: E48-E49.
26.
Fischer-Valuck BW, Robinson CG, Simone CB et al. Challenges in re-irradiation in the thorax: Managing patients with locally recurrent non-small cell lung cancer. Semin Radiat Oncol 2020; 30: 223-231.
